NCT06848400
Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Start date: Mar 3, 2025 to Apr 3, 2025 Show 8 more changesShow less
- Eligibility criteria expanded, about 10 words
- Trial completed
- Primary completion date changed from estimate of Dec 31, 2026 to Feb 18, 2026
- Secondary endpoints: details revised at 11 of 13 entries
- Study description expanded, about 8 words
- Site details revised at 12 of 12 sites
- Collaborators: 11 to 10
- Publications: details revised at 6 of 8 entries
Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
- Study sites: 1 to 12
- Start date changed from estimate of Mar 1, 2025 to Mar 3, 2025
- Study description expanded, about 269 words
- Collaborators: 1 to 11
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (12)
Show 7 moreShow less
Arms and interventions
Product name: Gastric Capsule Endoscope System Specification model: GICE-1000 Manufacturer: Guangzhou Side Medical Technology Co., Ltd. Participants fast for at least 8 hours and take mucolytics and anti-foaming agents 30 minutes before the ACG. Following video instructions, they connect the capsule with mobile, activate the capsule, and swallow it with water. Participants remain blinded to real-time ACG video. Researchers observe and record whether the participants have completed the examination as instructed in the video and any adverse events (without guidance). Data will be uploaded post-exam via WiFi or the manufacturer's system. Capsule discharge will be tracked.
Product name: Electronic gastrointestinal endoscope (EGD) Specifications and models: GIF-290 series Manufacturer: Olympus, Tokyo, Japan EGD was the reference standard against which ACG was compared, and it was performed within 24 hours post-ACG ingestion time. Participants will fast for at least 8 hours (clear water is allowed) and take mucolytics and anti-foaming agents 30 minutes before the EGD. The EGD will then be performed by endoscopists with more than 500 EGD procedures completed, who are blinded to the ACG examination results. The procedure for this study will adhere to the Systematic Screening Protocol for the Stomach (SSS), as outlined by Yao et al(8).The endoscopists will record any lesions identified (including lesion type, location, size, number of lesions etc.), and biopsies or treatments will be performed following white-light EGD screening, if necessary. Anonymous reports, images, and videos will be exported for further analysis.
Devices: AI-integrated Capsule Gastroscopy (ACG) examination, Electronic gastroduodenoscopy (EGD) examination
Sites
12 sites in 3 countries
China 10, Hong Kong 1, Italy 1